# US 2008/0076156 A1 · Process for production of recombinant proteins as a soluble form

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0076156 A1
- Document ID: US20080076156A1
- Status: Published application
- Kind: A1
- Application number: 11/902,030
- Filed: 2007-09-18
- Published: 2008-03-27
- Earliest claimed: 2006-09-19
- Assignees: Chisso Corporation
- Inventors: Satoshi Inouye; Yuiko Sahara
- Web page: https://patentgrep.com/patent/US20080076156A1

## CPC

- C07K 14/31: from Staphylococcus (G)
- C12N 9/0069: {acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)}
- C12N 15/62: DNA sequences coding for fusion proteins
- C07K 2319/61: containing an enzyme fusion for detection (lacZ, luciferase)
- C07K 2319/705: containing a protein-A fusion
- C12Y 113/12005: Renilla-luciferin 2-monooxygenase (1.13.12.5), i.e. renilla-luciferase
- C12Y 113/12007: Photinus-luciferin 4-monooxygenase (ATP-hydrolysing) (1.13.12.7), i.e. firefly-luciferase
- C12Y 113/12013: Oplophorus-luciferin 2-monooxygenase (1.13.12.13)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

A target protein is prepared as soluble protein using a recombinant protein expression system. An expression vector is used that includes (1) an expression-inducible promoter sequence; (2) a first coding sequence including a polynucleotide coding for a polypeptide that is represented by the formula (Z)n; and (3) a second coding sequence that includes a polynucleotide that codes for a target protein. A method of producing the target protein is also used that includes expressing protein using this expression vector.

## Claims

### Claim 1

An expression vector, comprising:
(1) an expression-inducible promoter sequence;
(2) a first coding sequence comprising a polynucleotide coding for a polypeptide that is represented by the formula (Z)n,
wherein n represents an integer from 1 to 5 and Z represents polypeptide selected from the group of:
(a) a polypeptide comprising the amino acid sequence of SEQ ID NO: 1,
(b) a polypeptide comprising an amino acid sequence with, in the amino acid sequence of SEQ ID NO: 1, one or more deleted, substituted, inserted and/or added amino acids,
(c) a polypeptide comprising an amino acid sequence that has at least approximately 90% identity with the amino acid sequence of SEQ ID NO: 1, and
(d) a polypeptide comprising an amino acid sequence that is encoded by a polynucleotide that hybridizes under stringent conditions with a polynucleotide comprising a base sequence that is complementary to the base sequence of SEQ ID NO: 2,
and that has the capacity when expressed as a fusion protein with a target protein to render said fusion protein expressible as a soluble protein; and
(3) a second coding sequence that comprises a polynucleotide that codes for a target protein.

### Claim 2 (depends on 1)

The vector according to claim 1, wherein the polypeptide represented by formula (Z)n is a polypeptide represented by (Z)2.

### Claim 3 (depends on 2)

The vector according to claim 2, wherein the polypeptide represented by (Z)2 is a polypeptide selected from the group of
(e) a polypeptide comprising the amino acid sequence of SEQ ID NO: 3,
(f) a polypeptide that comprises an amino acid sequence with, in the amino acid sequence of SEQ ID NO: 3, one or more deleted, substituted, inserted and/or added amino acids, and that has the capacity when expressed as a fusion protein with a target protein to render said fusion protein expressible as a soluble protein,
(g) a polypeptide that comprises an amino acid sequence having at least approximately 90% identity with the amino acid sequence of SEQ ID NO: 3, and that has the capacity when expressed as a fusion protein with a target protein to render said fusion protein expressible as a soluble protein, and
(h) a polypeptide comprising an amino acid sequence that is encoded by a polynucleotide that hybridizes under stringent conditions with a polynucleotide comprising a base sequence that is complementary to the base sequence of SEQ ID NO: 4, and having the capacity when expressed as a fusion protein with a target protein to render said fusion protein expressible as a soluble protein.

### Claim 4 (depends on 1)

The vector according to claim 1, wherein the expression-inducible promoter sequence is a low-temperature expression-inducible promoter sequence.

### Claim 5 (depends on 4)

The vector according to claim 4, wherein the low-temperature expression-inducible promoter sequence is a promoter sequence for a cold shock gene.

### Claim 6 (depends on 5)

The vector according to claim 5, wherein the promoter sequence for a cold shock gene is a promoter sequence for an Escherichia coli cold shock gene.

### Claim 7 (depends on 6)

The vector according to claim 6, wherein the promoter sequence for an Escherichia coli cold shock gene is a promoter sequence for at least one of the Escherichia coli cold shock gene cspA, cspB, cspG, cspI, and csdA.

### Claim 8 (depends on 1)

The vector according to claim 1, further comprising, between the first coding sequence and the second coding sequence, a coding sequence comprising a polynucleotide coding for a cleavable linker peptide.

### Claim 9 (depends on 8)

The vector according to claim 8, wherein the cleavable linker peptide is a linker peptide having a protease cleavage site.

### Claim 10 (depends on 1)

The vector according to claim 1, further comprising, on the 5′ side of the first coding sequence, a coding sequence that comprises a polynucleotide that encodes an amino acid sequence that facilitates purification.

### Claim 11 (depends on 10)

The vector according to claim 10, wherein the amino acid sequence that facilitates the purification is a histidine tag sequence.

### Claim 12

An expression vector, comprising:
(1) an expression-inducible promoter sequence;
(2) a first coding sequence comprising a polynucleotide coding for a polypeptide that is represented by the formula (Z)n,
wherein n represents an integer from 1 to 5 and Z represents polypeptide selected from the group of:
(a) a polypeptide comprising the amino acid sequence of SEQ ID NO: 1,
(b) a polypeptide comprising an amino acid sequence with, in the amino acid sequence of SEQ ID NO: 1, one or more deleted, substituted, inserted and/or added amino acids,
(c) a polypeptide comprising an amino acid sequence that has at least approximately 90% identity with the amino acid sequence of SEQ ID NO: 1, and
(d) a polypeptide comprising an amino acid sequence that is encoded by a polynucleotide that hybridizes under stringent conditions with a polynucleotide comprising a base sequence that is complementary to the base sequence of SEQ ID NO: 2,
and that has the capacity when expressed as a fusion protein with a target protein to render said fusion protein expressible as a soluble protein; and
(3) at least one restriction enzyme site that enables the insertion of a second coding sequence that comprises a polynucleotide that codes for a target protein.

### Claim 13 (depends on 12)

The vector according to claim 12, wherein the polypeptide represented by formula (Z)n is a polypeptide represented by (Z)2.

### Claim 14 (depends on 13)

The vector according to claim 13, wherein the polypeptide represented by (Z)2 is a polypeptide selected from the group of
(e) a polypeptide comprising the amino acid sequence of SEQ ID NO: 3,
(f) a polypeptide that comprises an amino acid sequence with, in the amino acid sequence of SEQ ID NO: 3, one or more deleted, substituted, inserted and/or added amino acids, and that has the capacity when expressed as a fusion protein with a target protein to render said fusion protein expressible as a soluble protein,
(g) a polypeptide that comprises an amino acid sequence having at least approximately 90% identity with the amino acid sequence of SEQ ID NO: 3, and that has the capacity when expressed as a fusion protein with a target protein to render said fusion protein expressible as a soluble protein, and
(h) a polypeptide comprising an amino acid sequence that is encoded by a polynucleotide that hybridizes under stringent conditions with a polynucleotide comprising a base sequence that is complementary to the base sequence of SEQ ID NO: 4, and having the capacity when expressed as a fusion protein with a target protein to render said fusion protein expressible as a soluble protein.

### Claim 15 (depends on 12)

The vector according to claim 12, wherein the expression-inducible promoter sequence is a low-temperature expression-inducible promoter sequence.

### Claim 16 (depends on 15)

The vector according to claim 15, wherein the low-temperature expression-inducible promoter sequence is a promoter sequence for a cold shock gene.

### Claim 17 (depends on 16)

The vector according to claim 16, wherein the promoter sequence for a cold shock gene is a promoter sequence for an Escherichia coli cold shock gene.

### Claim 18 (depends on 17)

The vector according to claim 17, wherein the promoter sequence for an Escherichia coli cold shock gene is a promoter sequence for at least on of the Escherichia coli cold shock gene cspA, cspB, cspG, cspI, and csdA.

### Claim 19 (depends on 12)

The vector according to claim 12, further comprising, between the first coding sequence and the second coding sequence, a coding sequence comprising a polynucleotide coding for a cleavable linker peptide.

### Claim 20 (depends on 19)

The vector according to claim 19, wherein the cleavable linker peptide is a linker peptide having a protease cleavage site.

### Claim 21 (depends on 12)

The vector according to claim 12, further comprising, on the 5′ side of the first coding sequence, a coding sequence that comprises a polynucleotide that encodes an amino acid sequence that facilitates purification.

### Claim 22 (depends on 21)

The vector according to claim 21, wherein the amino acid sequence that facilitates the purification is a histidine tag sequence.

### Claim 23

A fusion protein that can be expressed as a soluble protein, comprising:
(1) a first amino acid sequence comprising the amino acid sequence of a polypeptide that is represented by the formula (Z)n,
wherein n represents an integer from 1 to 5 and Z represents polypeptide selected from the group of:
(a) a polypeptide comprising the amino acid sequence of SEQ ID NO: 1,
(b) a polypeptide comprising an amino acid sequence with, in the amino acid sequence of SEQ ID NO: 1, one or more deleted, substituted, inserted and/or added amino acids,
(c) a polypeptide comprising an amino acid sequence that has at least approximately 90% identity with the amino acid sequence of SEQ ID NO: 1, and
(d) a polypeptide comprising an amino acid sequence that is encoded by a polynucleotide that hybridizes under stringent conditions with a polynucleotide comprising a base sequence that is complementary to the base sequence of SEQ ID NO: 2,
and that has the capacity when expressed as a fusion protein with a target protein to render said fusion protein expressible as a soluble protein; and
(2) a second amino acid sequence comprising the amino acid sequence of a target protein.

### Claim 24 (depends on 23)

The fusion protein according to claim 23, wherein the polypeptide represented by formula (Z)n is a polypeptide represented by (Z)2.

### Claim 25 (depends on 24)

The fusion protein according to claim 24, wherein the polypeptide represented by (Z)2 is a polypeptide selected from the group of
(e) a polypeptide comprising the amino acid sequence of SEQ ID NO: 3,
(f) a polypeptide that comprises an amino acid sequence with, in the amino acid sequence of SEQ ID NO: 3, one or more deleted, substituted, inserted and/or added amino acids, and that has the capacity when expressed as a fusion protein with a target protein to render said fusion protein expressible as a soluble protein,
(g) a polypeptide that comprises an amino acid sequence having at least approximately 90% identity with the amino acid sequence of SEQ ID NO: 3, and that has the capacity when expressed as a fusion protein with a target protein to render said fusion protein expressible as a soluble protein, and
(h) a polypeptide comprising an amino acid sequence that is encoded by a polynucleotide that hybridizes under stringent conditions with a polynucleotide comprising a base sequence that is complementary to the base sequence of SEQ ID NO: 4, and having the capacity when expressed as a fusion protein with a target protein to render said fusion protein expressible as a soluble protein.

### Claim 26 (depends on 23)

The fusion protein according to claim 23, wherein the target protein is at least one selected from the group of apoaequorin, Gaussia luciferase, and Oplophorus luciferase.

### Claim 27 (depends on 23)

The fusion protein according to claim 23, further comprising, between the first amino acid sequence and the second amino acid sequence, an amino acid sequence comprising the amino acid sequence of a cleavable linker peptide.

### Claim 28 (depends on 27)

The fusion protein according to claim 27, wherein the cleavable linker peptide is a linker peptide having a protease cleavage site.

### Claim 29 (depends on 23)

The fusion protein according to claim 23, further comprising, on the amino terminal side of the first amino acid sequence, an amino acid sequence that facilitates purification.

### Claim 30 (depends on 29)

The fusion protein according to claim 29, wherein the amino acid sequence that facilitates the purification is a histidine tag sequence.

### Claim 31

A fusion protein that can be expressed as a soluble protein and that is represented by the formula (Z)n-L-X,
wherein n represents an integer from 1 to 5; L represents a cleavable linker peptide; Z represents polypeptide selected from the group of:
(a) a polypeptide comprising the amino acid sequence of SEQ ID NO: 1,
(b) a polypeptide comprising an amino acid sequence with, in the amino acid sequence of SEQ ID NO: 1, one or more deleted, substituted, inserted and/or added amino acids,
(c) a polypeptide comprising an amino acid sequence that has at least approximately 90% identity with the amino acid sequence of SEQ ID NO: 1, and
(d) a polypeptide comprising an amino acid sequence that is encoded by a polynucleotide that hybridizes under stringent conditions with a polynucleotide comprising a base sequence that is complementary to the base sequence of SEQ ID NO: 2; and
X represents the amino acid sequence of a target protein.

### Claim 32 (depends on 31)

The fusion protein according to claim 31, wherein the target protein is any one selected from the group of apoaequorin, Gaussia luciferase, and Oplophorus luciferase.

### Claim 33 (depends on 23)

A polynucleotide comprising a polynucleotide that codes for the fusion protein according to claim 23.

### Claim 34 (depends on 33)

The polynucleotide according to claim 33, that is DNA.

### Claim 35

A method of producing a target protein as a soluble protein, comprising causing the expression of protein using an expression vector which comprises:
(1) an expression-inducible promoter sequence;
(2) a first coding sequence comprising a polynucleotide coding for polypeptide that is represented by the formula (Z)n,
wherein n represents an integer from 1 to 5 and Z represents polypeptide selected from the group of:
(a) a polypeptide comprising the amino acid sequence of SEQ ID NO: 1,
(b) a polypeptide comprising an amino acid sequence with, in the amino acid sequence of SEQ ID NO: 1, one or more deleted, substituted, inserted and/or added amino acids,
(c) a polypeptide comprising an amino acid sequence that has at least approximately 90% identity with the amino acid sequence of SEQ ID NO: 1, and
(d) a polypeptide comprising an amino acid sequence that is encoded by a polynucleotide that hybridizes under stringent conditions with a polynucleotide comprising a base sequence that is complementary to the base sequence of SEQ ID NO: 2,
and that has the capacity when expressed as a fusion protein with a target protein to render said fusion protein expressible as a soluble protein; and
(3) a second coding sequence that comprises a polynucleotide that codes for a target protein.

### Claim 36 (depends on 35)

The method according to claim 35, wherein the polypeptide represented by formula (Z)n is a polypeptide represented by (Z)2.

### Claim 37 (depends on 36)

The method according to claim 36, wherein the polypeptide represented by the formula (Z)2 is a polypeptide selected from the group of
(e) a polypeptide comprising the amino acid sequence of SEQ ID NO: 3,
(f) a polypeptide that comprises an amino acid sequence with, in the amino acid sequence of SEQ ID NO: 3, one or more deleted, substituted, inserted and/or added amino acids, and that has the capacity when expressed as a fusion protein with a target protein to render said fusion protein expressible as a soluble protein,
(g) a polypeptide that comprises an amino acid sequence having at least approximately 90% identity with the amino acid sequence of SEQ ID NO: 3, and that has the capacity when expressed as a fusion protein with a target protein to render said fusion protein expressible as a soluble protein, and
(h) a polypeptide comprising an amino acid sequence that is encoded by a polynucleotide that hybridizes under stringent conditions with a polynucleotide comprising a base sequence that is complementary to the base sequence of SEQ ID NO: 4, and having the capacity when expressed as a fusion protein with a target protein to render said fusion protein expressible as a soluble protein.

### Claim 38 (depends on 35)

The method according to claim 35, wherein the expression-inducible promoter sequence is a low-temperature expression-inducible promoter sequence.

### Claim 39 (depends on 38)

The method according to claim 38, wherein the low-temperature expression-inducible promoter sequence is a promoter sequence for a cold shock gene.

### Claim 40 (depends on 39)

The method according to claim 39, wherein the promoter sequence for a cold shock gene is a promoter sequence for an Escherichia coli cold shock gene.

### Claim 41 (depends on 40)

The method according to claim 40, wherein the promoter sequence for an Escherichia coli cold shock gene is a promoter sequence for at least one the Escherichia coli cold shock gene cspA, cspB, cspG, cspI, and csdA.

### Claim 42 (depends on 35)

The method according to claim 35, further comprising, between the first coding sequence and the second coding sequence, a coding sequence comprising a polynucleotide coding for a cleavable linker peptide.

### Claim 43 (depends on 42)

The method according to claim 42, wherein the cleavable linker peptide is a linker peptide having a protease cleavage site.

### Claim 44 (depends on 35)

The method according to claim 35, further comprising, on the 5′ side of the first coding sequence, a coding sequence that comprises a polynucleotide that encodes an amino acid sequence that facilitates purification.

### Claim 45 (depends on 44)

The method according to claim 44, wherein the amino acid sequence that facilitates the purification is a histidine tag sequence.
